Knowledge Center
Poster / Nov 12, 2017
Optimizing Disintegration in Tablets of Amorphous Solid Dispersions
Source:
AAPS 2017
Good bioavailability of amorphous solid dispersions (ASDs) not only depends on dissolution rate/extent but also on the capability to inhibit/avoid crystallization, ensuring that supersaturated state is retained to promote absorption. Here, the type and amount of carrier polymer used in ADSs preparation have a strong impact on the rate and extent of precipitation.
Also in the Knowledge Center
/ Dec 28, 2016
Electrophilic reagents for monohalomethylation, their preparation and their uses
Read more
Scientific Article
/ Dec 28, 2016
Continuous production of particles, micro- and/or nanoparticles, particulate amorphous solid dispersions, particulate co-crystals and pharmaceutical compns.
Read more
Scientific Article
/ Oct 23, 2016
Dry-Powder Inhalation Formulation: Balancing Performance and Manufacturability
Read more
Scientific Article